Adequan® returns as The Official Joint Therapy Treatment of the USEA and Title Sponsor of the $60,000 Adequan® USEA Advanced Final.
The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC).
“For over 15 years Adequan® has supported our horses and riders,” said USEA CEO Rob Burk. “Adequan® continues to invest in U.S. Eventing and they recently increased their support by offering unparalleled prize money in the Adequan® USEA Advanced Final. We are proud to have Adequan® as ‘The Official Joint Therapy of the USEA’ and we are very thankful for everything they do for the eventing community.”
As the Title Sponsor of the Adequan® USEA Advanced Final, Adequan® will generously provide $60,000 in prize money to the top finishers. The $60,000 Adequan® USEA Advanced Final will take place during the 2021 AEC on August 31 - September 5, 2021, at the Kentucky Horse Park in Lexington, Kentucky. As a Contributing Level Sponsor of the AEC, Adequan® will also provide prizes for every AEC division.
“We’re excited to continue partnering with USEA to help keep horses moving with Adequan® i.m.,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We’re looking forward to another season of competition and camaraderie.”
About the $60,000 Adequan® USEA Advanced Final
The $60,000 Adequan® USEA Advanced Final will take place at the 2021 USEA American Eventing Championships presented by Nutrena Feeds at the Kentucky Horse Park in Lexington, Kentucky, August 31 – September 5, 2021. Thanks to Adequan’s amazing support, the Adequan® USEA Advanced Final will bring together the country’s top riders to vie for $60,000 in prize money and the title of Adequan® Champion. To qualify for the $60,000 Adequan® USEA Advanced Final at the AEC in 2021, competitors will need to complete a minimum of two events without cross-country jump penalties at any USEA recognized Advanced horse trials, CCI4*-S, CCI4*-L , or CCI5*-L . The qualifying period for the 2021 AEC is May 25, 2020 through August 23, 2021. Click here to learn more about the $60,000 Adequan® USEA Advanced Final.
About American Regent Animal Health
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.
There were surprisingly few shakeups to the top of the leaderboards Friday at the MARS Bromont CCI, but the incredibly close scores leave no margin for error heading into Saturday’s exciting cross-country phase across all five levels.
Tomorrow, the first of five regional clinics for the USEA Emerging Athletes U21 (EA21) Program kicks off in the central region of the country in Benton, Louisiana, at Holly Hill Farm. Throughout the summer, the remaining clinics on the East and West Coast will follow. At each clinic, 12 hand-selected riders will participate in a two-day clinic led by USEA Eventing Coaches Program (ECP) coaches. The purpose of the EA21 program is to create a pipeline for potential team riders by identifying and developing young talent, improving horsemanship and riding skills, and training and improving skills and consistency. The intention is to provide young athletes with access to an added level of horsemanship and riding skills to further their training and skill development with greater consistency.
After the first day of competition, Canadian Olympian Colleen Loach and her horse FE Golden Eye lead an international field in the CCI4*-L division of the MARS Bromont CCI.